ClinicalTrials.Veeva

Menu

Colorectal Cancer Dataset in Xijing Hospital From 2011

A

Air Force Military Medical University of People's Liberation Army

Status

Enrolling

Conditions

Chemotherapy
Nutrition Related Cancer
Prognostic Cancer Model

Study type

Observational

Funder types

Other

Identifiers

NCT06308354
CRC dataset

Details and patient eligibility

About

To compare the differences of clinical pathological, treatment and prognosis in the guided subgroups in colorectal cancer, the investigator enrolled all the colorectal cancer patients who underwent surgery and were hospitalized in the Xijing hospital.

Enrollment

40,000 estimated patients

Sex

All

Ages

18 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

    1. Pathologically confirmed colorectal adenocarcinoma, including hereditary colorectal cancer syndrome, such as Lynch syndrome and familial adenocarcinoma tumor polyposis, Peutz Jeghers syndrome, juvenile polyposis syndrome, and serrated polyposis syndrome;
    1. Visit our center with complete medical records and pathological information;
    1. Colorectal cancer patients diagnosed between 2013 and 2023.

Exclusion criteria

    1. The patient has other colorectal malignancies other than adenocarcinoma;
    1. Malignant tumors adjacent to organs invading the colon and rectum;
    1. Malignant tumors from distant organs metastasize to the colon and rectum;
    1. Benign colorectal lesions; 5. Patients with recurrent colorectal cancer.

Trial design

40,000 participants in 1 patient group

colorectal cancer
Description:
Colorectal cancer patients are enrolled when patients were underwent surgeries.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems